| GROW (Glioma Specialists Reaching Out With Support) Support (NCT05233215) | Dana-Farber Cancer Institute | 2022-07-01 |
| Evaluation of Cognitive and Motor Neurological Disorders in the Short and Long Term After Surgery for the Removal of a Diffuse Low-grade Glioma of the Supplementary Motor Area (NCT05373394) | University Hospital, Tours | 2022-05-19 |
| A Living Tissue Bank of Patient-Derived Organoids From Glioma Tumors (NCT04865315) | Maastricht Radiation Oncology | 2022-05-01 |
| A Phase II Trial of Poly-ICLC for Low-Grade Gliomas (NCT04544007) | University of Alabama at Birmingham | 2022-02-08 |
| SonoClear Acoustic Coupling Fluid (ACF) Mimicking Brain Tissue (NCT04734444) | SonoClear AS | 2021-09-01 |
| SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma (NCT04923126) | St. Jude Children's Research Hospital | 2021-06-21 |
| Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021) (NCT04485559) | University of California, San Francisco | 2020-12-09 |
| Child's Study of the Impact of PF Lesion on Motor Skills, Language, Cognitive Functioning and Social Cognition (NCT04174820) | University Hospital, Angers | 2020-11-12 |
| Study of Recombinant Human Endostatin Combined With CV Regimen in the Treatment of Pediatric Low-grade Gliomas (NCT04659421) | Beijing Sanbo Brain Hospital | 2020-11-03 |
| Trial in Low Grade Glioma Patients: Wait or Treat (NCT03763422) | European Organisation for Research and Treatment of Cancer - EORTC | 2020-03-16 |
| A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma (NCT04166409) | National Cancer Institute (NCI) | 2020-01-31 |
| A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma (NCT03871257) | National Cancer Institute (NCI) | 2020-01-15 |
| Studying the Biology of IDH-mutant Gliomas Via Longitudinal Observation of 2-hydroxyglutarate (2-HG) Using MR Spectroscopy (NCT03952598) | National Cancer Institute (NCI) | 2019-10-16 |
| Rehabilitation and Longitudinal Follow-up of Cognition in Adult Lower Grade Gliomas (NCT03948490) | University of California, San Francisco | 2019-06-07 |
| BGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV Gliomas (NCT03749187) | University of California, San Francisco | 2019-04-03 |
| Nivolumab in Patients With IDH-Mutant Gliomas With and Without Hypermutator Phenotype (NCT03718767) | National Cancer Institute (NCI) | 2019-03-27 |
| Fluoroethyltyrosine for Evaluation of Intracranial Neoplasms (NCT04044937) | Thomas Hope | 2018-10-29 |
| Trametinib for Pediatric Neuro-oncology Patients With Refractory Tumor and Activation of the MAPK/ERK Pathway. (NCT03363217) | St. Justine's Hospital | 2018-08-16 |
| Assessing the Effectiveness of 2D Non-Navigated Intraoperative Ultrasound in Glioma Surgery (NCT05873946) | Hospital del Rio Hortega | 2018-06-01 |
| Radiotherapy Versus Radiotherapy Combined With Temozolomide in High-risk Low-grade Gliomas After Surgery (NCT04316039) | West China Hospital | 2018-04-10 |
| DAY101 In Gliomas and Other Tumors (NCT03429803) | Karen D. Wright, MD | 2018-02-27 |
| Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial) (NCT03213665) | National Cancer Institute (NCI) | 2017-11-13 |
| Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial) (NCT03233204) | National Cancer Institute (NCI) | 2017-09-14 |
| Mind-Body Intervention in Glioma Couples (NCT03244995) | M.D. Anderson Cancer Center | 2017-08-06 |
| Vinblastine +/- Bevacizumab in Children With Unresectable or Progressive Low Grade Glioma (LGG) (NCT02840409) | The Hospital for Sick Children | 2016-08-01 |
| Longitudinal MRI Assessment in Patients With Diffuse Low-grade Gliomas (NCT04346472) | University Hospital, Montpellier | 2016-03-01 |
| ROCOCO - Low Grade Glioma - Planning Study (NCT02607397) | Maastricht Radiation Oncology | 2015-05-01 |
| A Study Comparing Two Carboplatin Containing Regimens for Children and Young Adults With Previously Untreated Low Grade Glioma (NCT02455245) | Alicia Lenzen | 2015-03-01 |
| A Vaccine Trial for Low Grade Gliomas (NCT02358187) | James Felker | 2015-01-01 |
| Phase II Trial of Oral Vinorelbine in Children With Recurrent or Progressive Unresectable Low-Grade Glioma (NCT02197637) | Centre Oscar Lambret | 2014-05-01 |
| Everolimus With and Without Temozolomide in Adult Low Grade Glioma (NCT02023905) | University of California, San Francisco | 2014-03-19 |
| Rotating Frame Relaxation and Diffusion Weighted Imaging of Human Gliomas (NCT02186262) | Turku University Hospital | 2014-03-01 |
| Ovarian Aging in Low Grade Glioma (LGG) Treated With Temozolomide (NCT01452854) | University of California, San Francisco | 2011-10-01 |
| Vinorelbine for Children With Progressive or Recurrent Low-grade Gliomas (NCT01497860) | Eugene Hwang | 2011-07-01 |
| Proton Radiation Therapy for Gliomas (NCT01358058) | Massachusetts General Hospital | 2011-05-01 |
| Proton Radiotherapy for Pediatric Brain Tumors Requiring Partial Brain Irradiation (NCT01288235) | Massachusetts General Hospital | 2011-02-01 |
| (11C)dLop as a Marker of P-Glycoprotein Function in Patients With Gliomas (NCT01281982) | National Cancer Institute (NCI) | 2011-01-13 |
| Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma (NCT01089101) | National Cancer Institute (NCI) | 2010-07-07 |
| Evaluation de O-(2-[18F]-Fluoroethyl)-L-Tyrosine, a New Tracer PET, in the Diagnosis of Low Grade Glioma (NCT02286531) | University Hospital, Toulouse | 2010-06-01 |
| Expanded Access Program (EAP) for Tovorafenib (DAY101) in RAF-Altered, Relapsed or Refractory Low-Grade Glioma (NCT05760586) | Day One Biopharmaceuticals, Inc. | |